Affiliation:
1. Department of Biostatistics The University of North Carolina at Chapel Hill Chapel Hill North Carolina USA
Abstract
A basket trial aims to expedite the drug development process by evaluating a new therapy in multiple populations within the same clinical trial. Each population, referred to as a “basket”, can be defined by disease type, biomarkers, or other patient characteristics. The objective of a basket trial is to identify the subset of baskets for which the new therapy shows promise. The conventional approach would be to analyze each of the baskets independently. Alternatively, several Bayesian dynamic borrowing methods have been proposed that share data across baskets when responses appear similar. These methods can achieve higher power than independent testing in exchange for a risk of some inflation in the type 1 error rate. In this paper we propose a frequentist approach to dynamic borrowing for basket trials using adaptive lasso. Through simulation studies we demonstrate adaptive lasso can achieve similar power and type 1 error to the existing Bayesian methods. The proposed approach has the benefit of being easier to implement and faster than existing methods. In addition, the adaptive lasso approach is very flexible: it can be extended to basket trials with any number of treatment arms and any type of endpoint.
Subject
Statistics and Probability,Epidemiology
Reference32 articles.
1. US Food and Drug Administration.Master Protocols: Efficient Clinical Trial Design Strategies to Expedite Development of Oncology Drugs and Biologics.2022https://www.fda.gov/media/120721/download
2. HER kinase inhibition in patients with HER2- and HER3-mutant cancers
3. Categories, components, and techniques in a modular construction of basket trials for application and further research